ATE118785T1 - Pentapeptidderivate, wirksam gegen herpes, die eine ersetzte asparaginsäureseitenkette enthalten. - Google Patents

Pentapeptidderivate, wirksam gegen herpes, die eine ersetzte asparaginsäureseitenkette enthalten.

Info

Publication number
ATE118785T1
ATE118785T1 AT90112646T AT90112646T ATE118785T1 AT E118785 T1 ATE118785 T1 AT E118785T1 AT 90112646 T AT90112646 T AT 90112646T AT 90112646 T AT90112646 T AT 90112646T AT E118785 T1 ATE118785 T1 AT E118785T1
Authority
AT
Austria
Prior art keywords
replaced
side chain
effective against
acid side
against herpes
Prior art date
Application number
AT90112646T
Other languages
English (en)
Inventor
Julian Adams
Pierre Louis Beaulieu
Robert Deziel
John Dimaio
Louis Grenier
Pierre Lavallee
Neil Moss
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA000605091A external-priority patent/CA1340683C/en
Priority claimed from CA002019005A external-priority patent/CA2019005C/en
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Application granted granted Critical
Publication of ATE118785T1 publication Critical patent/ATE118785T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
AT90112646T 1989-07-07 1990-07-03 Pentapeptidderivate, wirksam gegen herpes, die eine ersetzte asparaginsäureseitenkette enthalten. ATE118785T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000605091A CA1340683C (en) 1989-07-07 1989-07-07 Antiherpes pentapeptides having a substituted aspartic acid side chain
CA002019005A CA2019005C (en) 1990-06-14 1990-06-14 Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain

Publications (1)

Publication Number Publication Date
ATE118785T1 true ATE118785T1 (de) 1995-03-15

Family

ID=25672870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90112646T ATE118785T1 (de) 1989-07-07 1990-07-03 Pentapeptidderivate, wirksam gegen herpes, die eine ersetzte asparaginsäureseitenkette enthalten.

Country Status (6)

Country Link
EP (1) EP0411334B1 (de)
JP (1) JP2877909B2 (de)
AT (1) ATE118785T1 (de)
DE (1) DE69017113T2 (de)
IL (1) IL94980A (de)
NZ (1) NZ234376A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830864A (en) * 1992-03-12 1998-11-03 Boehringer Ingelheim (Canada), Ltd. Antiherpes peptide derivatives having a ureido n-terminus
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
ATE169931T1 (de) 1992-03-12 1998-09-15 Boehringer Ingelheim Ca Ltd Isosterische peptidderivate gegen herpes
EP0618226B1 (de) * 1993-03-03 2000-11-29 Boehringer Ingelheim (Canada) Ltd. Hemmstoff für Ribonukleotid-Reduktase von Herpesviren
CA2152541C (en) * 1995-06-23 1998-12-15 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Herpes ribonucleotide reductase inhibitors
US5948935A (en) * 1997-01-23 1999-09-07 Boehringer Ingelheim (Canada) Ltd. Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid
JP5828217B2 (ja) 2011-04-15 2015-12-02 三菱マテリアル株式会社 ドリル

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
EP0292255A3 (de) * 1987-05-22 1990-08-22 Merck & Co. Inc. Hemmungsstoff für Ribonukleotid-Reduktase

Also Published As

Publication number Publication date
EP0411334B1 (de) 1995-02-22
JPH03215497A (ja) 1991-09-20
EP0411334A1 (de) 1991-02-06
IL94980A (en) 1995-03-15
DE69017113D1 (de) 1995-03-30
IL94980A0 (en) 1991-06-10
DE69017113T2 (de) 1995-08-03
NZ234376A (en) 1997-05-26
JP2877909B2 (ja) 1999-04-05

Similar Documents

Publication Publication Date Title
EP0425429A3 (de) Lichtstabilisierte Tinten
ATE184194T1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)- homoserinlacton
PL301581A1 (en) Novel hiv protease inhibitors, method of obtaining such inhibitors and pharmaceutical preparation
ATE217635T1 (de) Zyklische peptide mit antifungischer wirkung und verfahren zu ihrer herstellung
GR3020451T3 (en) Retroviral protease inhibitors
NZ236327A (en) Substituted pyrrolidines and piperidines, and use thereof for preparing amino acid derivatives
HUT47529A (en) Process for producing polyethyleneglycol-carbaminates and diagnostic and pharmaceutical compositions comprising such compounds
HU9502811D0 (en) N-acyl-sulfamic acid esters (or thioesters), n-acyl-sulfonamides and n-sulfonyl-carbamic-acid-esters (or thioesters) as hypercholesterolemic agents
IT1274250B (it) Dieteri utilizzabili nella preparazione di catalizzatori ziegler-natta
GR3024586T3 (en) Retroviral protease inhibitors
ATE118785T1 (de) Pentapeptidderivate, wirksam gegen herpes, die eine ersetzte asparaginsäureseitenkette enthalten.
DE69023977D1 (de) Antivirale Peptide, die eine 2-Ketoalkylaminosäureseitenkette enthalten.
ATE179423T1 (de) Phosphorsubstituierte isoprenderivate
AU7468581A (en) Removing cobalt(ii) from aqueous solutions
FI944187A0 (fi) Isosteeriset antiherpespeptidijohdannaiset
DE3888569D1 (de) Schmierölzusammensetzungen, die Antiverschleiss- oder Extremdruckadditive enthalten.
HU902612D0 (en) Process for the preparation of 4-phenylmethyl-1h-indole derivatives
ATE123294T1 (de) Antiherpes-tetrapeptid-derivate mit einer substituierten seitenkette aus asparaginsäure.
ATE144534T1 (de) Antiherpes-pentapeptide
CA2019005A1 (en) Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain
CA1267150C (en) THIABICYCLOHEPTANE SUBSTITUTION DERIVATIVES OF AMINO-PROSTAGLANDIN ANALOGS
CA2019006A1 (en) Antiherpes tetrapeptide derivatives having a cycloalkyl substituted aspartic acid side chain
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
DE69319266D1 (de) Peptidderivate mit einem Ureido-N-Terminus gegen Herpes
DE69514388D1 (de) Antiherpetische peptidomimetische verbindungen